Due Diligence at its finest
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PPCH - Propanc, together with its scientific and oncology consultants, has developed a rational, composite formulation of anti-cancer compounds which together exert a number of anti-cancer actions. http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - aims to fast-track development of proenzyme-related oncology products into clinical trials, initially for colorectal and pancreatic tumors. The world market for colorectal cancer is expected to reach $8.8 billion by 2020 and the global pancreatic cancer market is projected to exceed $1.2 billion by the year 2015, according to Global Analyst Reports http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Dr Kenyon, Chief Scientific Officer of Propanc Health Group, states, "After a detailed strategic review of our scientific and preclinical research, our development team determined I.V. injection as the preferred route of administration. This approach would be the best way to maximise results in future patient trials, by ensuring maximum exposure of the drug to the tumor site." http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
Yep Always on Twitter. Get some of my best alerts there. $PPCH - Dr Kenyon, Chief Scientific Officer of Propanc Health Group, states, "After a detailed strategic review of our scientific and preclinical research, our development team determined I.V. injection as the preferred route of administration. This approach would be the best way to maximise results in future patient trials, by ensuring maximum exposure of the drug to the tumor site." http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$OGNG AirMax 3000 can produce a gallon of water for $.03 to $.08 per gallon (3.78 liters) http://www.splashwaterforlife.com/Max
$OGNG AirMax 3000 can produce a gallon of water for $.03 to $.08 per gallon (3.78 liters) http://www.splashwaterforlife.com/Max
$OGNG AirMax 3000 produces up to 8 gallons of water per day based on relative humidity and temperature http://www.splashwaterforlife.com/Max
$OGNG AirMax 3000 produces up to 8 gallons of water per day based on relative humidity and temperature http://www.splashwaterforlife.com/Max
$OGNG AirWell 3000 can operate in areas where there is no power available without the use of an electric generator http://www.splashwaterforlife.com/Well
$OGNG AirWell 3000 can operate in areas where there is no power available without the use of an electric generator http://www.splashwaterforlife.com/Well
$OGNG AirWell 3000 intended use of these machines are for use in military camps and humanitarian and disaster relief applications where fresh drinking water is scarce, unavailable or difficult to access. In addition, these machines provide clean water for commercial applications such as in beverage and food manufacturing, for industrial work sites & organizations in remote locations including schools, resorts, hospitals & resource companies
http://www.splashwaterforlife.com/Well
$OGNG AirWell 3000 intended use of these machines are for use in military camps and humanitarian and disaster relief applications where fresh drinking water is scarce, unavailable or difficult to access. In addition, these machines provide clean water for commercial applications such as in beverage and food manufacturing, for industrial work sites & organizations in remote locations including schools, resorts, hospitals & resource companies
http://www.splashwaterforlife.com/Well
$PPCH Seeking worldwide regulatory approval in several indications, targeting tumor types http://www.propanc.com
$PPCH Seeking worldwide regulatory approval in several indications, targeting tumor types http://www.propanc.com
$PPCH Targeted therapy for metastatic cancer http://www.propanc.com
$PPCH Targeted therapy for metastatic cancer http://www.propanc.com
Visit $OGNG website: www.bravoenterprises.ws or www.splashwaterforlife.com
Visit $OGNG website: www.bravoenterprises.ws or www.splashwaterforlife.com
$OGNG Bravo has the exclusive manufacturing, marketing and distribution rights worldwide for its AIRMAX 3000 and AIRWELL 3000 atmospheric water harvesting machines, production models developed exclusively for the generation of clean, safe drinking water for human consumption.
$OGNG Bravo has the exclusive manufacturing, marketing and distribution rights worldwide for its AIRMAX 3000 and AIRWELL 3000 atmospheric water harvesting machines, production models developed exclusively for the generation of clean, safe drinking water for human consumption.
$PPCH - Propanc Health Group progressing development of a once-daily proteolytic proenzyme cancer treatment http://www.propanc.com
$PPCH - Propanc Health Group progressing development of a once-daily proteolytic proenzyme cancer treatment http://www.propanc.com
$PPCH - Propanc Health Group Highlights http://www.propanc.com/who-we-are/key-highlights.php
$PPCH - Propanc Health Group Highlights http://www.propanc.com/who-we-are/key-highlights.php
$CBIS - Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. http://www.cannabisscience.com/
$CBIS - Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. http://www.cannabisscience.com/
$CBIS - Cannabis Science Inc. Signs Agreement With MEDIWIET to Conduct Clinical Observational Study in the Netherlands 4/30/14 http://finance.yahoo.com/news/cannabis-science-inc-signs-agreement-121200761.html?soc_src=mediacontentstory
$CBIS - Cannabis Science Inc. Signs Agreement With MEDIWIET to Conduct Clinical Observational Study in the Netherlands 4/30/14 http://finance.yahoo.com/news/cannabis-science-inc-signs-agreement-121200761.html?soc_src=mediacontentstory
Bravo Enterprises (OTCQB: OGNG) Receives Official FEMA Recognition
Bravo Enterprises (OTCQB: OGNG) Receives Official FEMA Recognition
$OGNG Splash Water Airmax 3000 Instructional Video
$OGNG Splash Water Airmax 3000 Instructional Video
$PPCH website: http://www.propanc.com
$PPCH website: http://www.propanc.com
$PPCH - Propanc Health Group Highlights
-Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
-Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist.
-Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
-Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
-Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of
administration and potential new targets
http://www.propanc.com
TY lol have hit some good ones lately $PPCH - Propanc Health Group Highlights
-Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
-Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist.
-Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
-Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
-Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of
administration and potential new targets
http://www.propanc.com
$CBIS - Cannabis Science is discussing the initiation of additional clinical studies using pharmaceutical grade cannabis in proprietary, topical and orally administered applications to various skin conditions including skin cancer work to be conducted in several geographic areas in collaboration with multiple potential partners http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
$CBIS - Cannabis Science is discussing the initiation of additional clinical studies using pharmaceutical grade cannabis in proprietary, topical and orally administered applications to various skin conditions including skin cancer work to be conducted in several geographic areas in collaboration with multiple potential partners http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
I certainly agree with you on that one. CBIS -"Cannabis Science has made solid progress so far this year. I am proud to be a part of this team and I am very positive about our future," stated Robert Kane, CFO of Cannabis Science. http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
CBIS -"Cannabis Science has made solid progress so far this year. I am proud to be a part of this team and I am very positive about our future," stated Robert Kane, CFO of Cannabis Science. http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U